Quality of Life in Patients with Loco-regional Rectal Cancer After ELRR by TEM Versus VLS TME After NChRT: Long-term Results

Overview

Journal Surg Endosc

Publisher Springer

Specialties Gastroenterology
General Surgery
Radiology

Date 2018 Nov 14

PMID 30421081

Citations 7

Authors

Giancarlo DAmbrosio

Andrea Picchetto

Salvatore Campo

Rossella Palma

Cristina Panetta

Francesca De Laurentis

Stefania La Rocca

Emanuele Lezoche

Affiliations

Soon will be listed here.

Abstract

Background: Endoluminal loco-regional resection (ELRR) by transanal endoscopic microsurgery (TEM) may be an alternative treatment option to Laparoscopic total mesorectal excision (LTME), in selected patients with N0 rectal cancer. Post-operative quality of life (QoL) evaluation is an important parameter of outcomes related to high percentage of functional sequelae. We reported, in a previous paper, the short and medium term results of QoL in patients who underwent ELRR or LTME. The aim is to evaluate the 3 year QoL in patients with iT2-T3 N0/+ rectal cancer who underwent ELRR by TEM or LTME after neoadjuvant radio-chemotherapy (nChRT) in a retrospective analysis of prospectively collected data.

Methods: We enrolled in this study, 39 patients with iT2-T3 rectal cancer who underwent ELRR (n = 19) or LTME (n = 20), according to predefined criteria. QoL was evaluated by EORTC QLQ-C30 and QLQ-CR38 questionnaires at admission, after n-RCT and 1, 6, 12, and 36 months after surgery.

Results: No statistically significant differences in QoL evaluation were observed between the two groups, both at admission and after n-RCT. In short term (1-6 months) period, significantly better results were observed in ELRR group by QLQ-C30 in global health status (p = 0.03), physical functioning (p = 0.026), role functioning (p = 0.04), emotional functioning (p = 0.04), cognitive functioning, fatigue (p < 0.05), dyspnoea (p < 0.001), insomnia (p < 0.05), appetite loss (p < 0.05), constipation (≤ 0.05), and by QLQ-CR38 in: body image (p = 0.03) and defecation (p = 0.025). At 1 year, the two groups were homogenous as assessed by QLQ-C30, whereas the QLQCR38 still showed better results of ELRR versus LTME in body image (p = 0.006), defecation problems (p = 0.01), and weight loss (p = 0.005). At 3 years, no statistically significant differences were observed between the two groups.

Conclusions: In selected patients with rectal cancer, who underwent ELRR by TEM or LTME, QoL tests at 3 years do not show any statistical differences on examined items.

Citing Articles

Assessment of cognitive function after surgery for colorectal cancer-a scoping review.

Ehrencrona C, Levenskog R, Angenete E BMJ Open. 2024; 14(12):e080950.

PMID: 39627132 PMC: 11624727. DOI: 10.1136/bmjopen-2023-080950.

Non-gastrointestinal symptom burden following colorectal cancer treatment-a systematic review.

Fernandes D, Nelson D, Ortega M, Siriwardena A, Law G, Andreyev J Support Care Cancer. 2024; 32(10):699.

PMID: 39361213 DOI: 10.1007/s00520-024-08903-7.

Long-term efficacy of transanal local excision versus total mesorectal excision after neoadjuvant treatment for rectal cancer: A meta-analysis.

Lei Y, Lin L, Shao Q, Chen W, Liu G PLoS One. 2023; 18(11):e0294510.

PMID: 37983236 PMC: 10659211. DOI: 10.1371/journal.pone.0294510.

Local Excision Versus Total Mesorectal Excision After Favourable Response to Neoadjuvant Therapy in Low Rectal Cancer: a Multi-centre Experience.

Fareed A, Eldamshety O, Shahatto F, Khater A, Kotb S, Elzahaby I Indian J Surg Oncol. 2023; 14(2):331-338.

PMID: 37324307 PMC: 10267030. DOI: 10.1007/s13193-022-01674-9.

Long-term outcomes of transanal endoscopic microsurgery for the treatment of rectal neuroendocrine tumors.

Shi W, Hou R, Li Y, Qiu X, Liu Y, Wu B BMC Surg. 2022; 22(1):43.

PMID: 35120483 PMC: 8817465. DOI: 10.1186/s12893-022-01494-2.

References

Buess G, Theiss R, HUTTERER F, Pichlmaier H, Pelz C, Holfeld T . [Transanal endoscopic surgery of the rectum - testing a new method in animal experiments]. Leber Magen Darm. 1983; 13(2):73-7. View

Heald R, Moran B, Ryall R, Sexton R, Macfarlane J . Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg. 1998; 133(8):894-9. DOI: 10.1001/archsurg.133.8.894. View

Heald R, Ryall R . Recurrence and survival after total mesorectal excision for rectal cancer. Lancet. 1986; 1(8496):1479-82. DOI: 10.1016/s0140-6736(86)91510-2. View

Dahlberg M, Glimelius B, Pahlman L . Improved survival and reduction in local failure rates after preoperative radiotherapy: evidence for the generalizability of the results of Swedish Rectal Cancer Trial. Ann Surg. 1999; 229(4):493-7. PMC: 1191734. DOI: 10.1097/00000658-199904000-00007. View

Grumann M, Noack E, Hoffmann I, Schlag P . Comparison of quality of life in patients undergoing abdominoperineal extirpation or anterior resection for rectal cancer. Ann Surg. 2001; 233(2):149-56. PMC: 1421194. DOI: 10.1097/00000658-200102000-00001. View

DAmbrosio G, Paganini A, Balla A, Quaresima S, Ursi P, Bruzzone P . Quality of life in non-early rectal cancer treated by neoadjuvant radio-chemotherapy and endoluminal loco-regional resection (ELRR) by transanal endoscopic microsurgery (TEM) versus laparoscopic total mesorectal excision. Surg Endosc. 2015; 30(2):504-511. DOI: 10.1007/s00464-015-4232-8. View

Camilleri-Brennan J, Steele R . Objective assessment of morbidity and quality of life after surgery for low rectal cancer. Colorectal Dis. 2003; 4(1):61-66. DOI: 10.1046/j.1463-1318.2002.00300.x. View

Biviano I, Balla A, Badiali D, Quaresima S, DAmbrosio G, Lezoche E . Anal function after endoluminal locoregional resection by transanal endoscopic microsurgery and radiotherapy for rectal cancer. Colorectal Dis. 2017; 19(6):O177-O185. DOI: 10.1111/codi.13656. View

Allaix M, Rebecchi F, Giaccone C, Mistrangelo M, Morino M . Long-term functional results and quality of life after transanal endoscopic microsurgery. Br J Surg. 2011; 98(11):1635-43. DOI: 10.1002/bjs.7584. View

10.

Lezoche E, Baldarelli M, Lezoche G, Paganini A, Gesuita R, Guerrieri M . Randomized clinical trial of endoluminal locoregional resection versus laparoscopic total mesorectal excision for T2 rectal cancer after neoadjuvant therapy. Br J Surg. 2012; 99(9):1211-8. DOI: 10.1002/bjs.8821. View

11.

Williams N, Johnston D . The quality of life after rectal excision for low rectal cancer. Br J Surg. 1983; 70(8):460-2. DOI: 10.1002/bjs.1800700805. View

12.

Valsdottir E, Yarandi S, Marks J, Marks G . Quality of life and fecal incontinence after transanal endoscopic microsurgery for benign and malignant rectal lesions. Surg Endosc. 2013; 28(1):193-202. DOI: 10.1007/s00464-013-3155-5. View

13.

Morino M, Parini U, Allaix M, Monasterolo G, Contul R, Garrone C . Male sexual and urinary function after laparoscopic total mesorectal excision. Surg Endosc. 2008; 23(6):1233-40. DOI: 10.1007/s00464-008-0136-1. View

14.

Lezoche E, Guerrieri M, Paganini A, Feliciotti F . Transanal endoscopic microsurgical excision of irradiated and nonirradiated rectal cancer. A 5-year experience. Surg Laparosc Endosc. 1998; 8(4):249-56. View

15.

Lezoche E, Guerrieri M, Paganini A, Baldarelli M, De Sanctis A, Lezoche G . Long-term results in patients with T2-3 N0 distal rectal cancer undergoing radiotherapy before transanal endoscopic microsurgery. Br J Surg. 2005; 92(12):1546-52. DOI: 10.1002/bjs.5178. View

16.

Dahlberg M, Glimelius B, Graf W, Pahlman L . Preoperative irradiation affects functional results after surgery for rectal cancer: results from a randomized study. Dis Colon Rectum. 1998; 41(5):543-9; discussion 549-51. DOI: 10.1007/BF02235256. View

17.

Doornebosch P, Gosselink M, Neijenhuis P, Schouten W, Tollenaar R, de Graaf E . Impact of transanal endoscopic microsurgery on functional outcome and quality of life. Int J Colorectal Dis. 2008; 23(7):709-13. PMC: 2386752. DOI: 10.1007/s00384-008-0442-z. View

18.

Feliciotti F, Guerrieri M, Paganini A, De Sanctis A, Campagnacci R, Perretta S . Long-term results of laparoscopic versus open resections for rectal cancer for 124 unselected patients. Surg Endosc. 2003; 17(10):1530-5. DOI: 10.1007/s00464-002-8874-y. View

19.

Sprangers M, Te Velde A, Aaronson N . The construction and testing of the EORTC colorectal cancer-specific quality of life questionnaire module (QLQ-CR38). European Organization for Research and Treatment of Cancer Study Group on Quality of Life. Eur J Cancer. 1999; 35(2):238-47. DOI: 10.1016/s0959-8049(98)00357-8. View

20.

Kuzu M, Topcu O, Ucar K, Ulukent S, Unal E, Erverdi N . Effect of sphincter-sacrificing surgery for rectal carcinoma on quality of life in Muslim patients. Dis Colon Rectum. 2002; 45(10):1359-66. DOI: 10.1007/s10350-004-6425-4. View